Home > Chemicals & Materials > Specialty Chemicals > Custom Synthesis > Erdosteine Market
Erdosteine Market Share
- Report ID: GMI3371
- Published Date: May 2021
- Report Format: PDF
Erdosteine Market Share
Global erdosteine industry share is consolidated, and the key players include:
- Reipharm AB
- Hanmi Pharmaceutical
- Hikma Pharmaceuticals
- Shandong Luoxin Pharmaceutical
- Zhejiang Kangle Pharmaceutical Co., Ltd
Various manufacturers are primarily focusing on strategic initiatives such as acquisitions, partnerships and joint ventures to expand product portfolio and achieve market growth. Leading companies are also engaged in significant research & development activities to expand the application potential of their products and gain additional customers.
For instance, Recipharm, a leading pharmaceutical company announced in 2020 that it was conducting research on its erdosteine product to investigate if it improved the recovery rate of COVID-19 patients after discharge from hospital. Various clinical studies were conducted to verify if the product enhances respiratory symptoms and reduces the time required to achieve a negative COVID-19 test result.
Frequently Asked Questions (FAQ) :
Erdosteine Market Scope
